
Bafna Pharma Announces 31st AGM on Sep 11, 2026
Bafna Pharmaceuticals Ltd has announced its 31st Annual General Meeting (AGM) will be held on Friday, September 11, 2026, at 10:00 AM IST. The meeting will be conducted via Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The company has engaged CDSL for E-Voting and VC/OAVM facilities. The Annual Report for the Financial Year 2025-2026 and the AGM notice are enclosed and have been sent to members electronically. The report highlights significant growth in FY26, with operating revenue of INR 1,506 million (3.26% growth), operating profit of INR 159 million (43% growth), and net profit of INR 111 million (167% growth). Bafna Pharmaceuticals operates a manufacturing facility with Tier-1 regulatory accreditations and exports to over 20 countries.
Key Highlights
- 31st AGM scheduled for September 11, 2026, via VC/OAVM.
- Annual Report for FY 2025-2026 released.
- Net profit surged 167% to INR 111 million in FY26.
- Operating revenue grew 3.26% to INR 1,506 million.
- Company exports to over 20 countries with strong regulatory approvals.
Price Impact
More from BAFNAPH